• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 3
  3. Author

Online ISSN: 2515-8260

Volume9, Issue3

Study on early detection of chromosomal anomalies, maternal outcome by performing biochemical and sonological tests between 11-14 wk of gestational age

    Dr Sudha Bhimavarapu, Dr A Rohini, Dr. VBhanupriya

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 3, Pages 10308-10318

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Introduction: Chromosomal disorders are caused by changes occurring in either
chromosome number or structure usually during the formation of gametes or soon after
fertilisation. These changes can affect the autosomes, with chromosomal disorders
divided into the two corresponding groups.
Aims: To screen for chromosomal abnormalities namely trisomy 21, 18 & 13, during the
first trimester of pregnancy using biochemical tests like freeβ-hCG, PAPP-A and ultra
sound measurements of nuchal translucency, nasal bone and ductus venosus flow.
Materials and methods:The Prospective study on early detection of chromosomal
anomalies by performing a combination of biochemical and sonological tests between
11-14 wk of gestation. To the existing first trimester screening tests of double marker (
free β- hCG and PAPP-A) Combined with NT,two more sonological markers were
added is NB,DVF to improve the diagnostic sensitivity.
Results: Mean age at presentation was 28yrs.Prevalence of high risk after the combined
test is 7%, none of them had chromosomal anomalies. However low PAPP-A (<0.52
MoM) was significantly associated with increased preeclampsia, preterm delivery and
miscarriage.Absent NT can also be an independent marker for identifying high risk
cases.
Conclusion: The analysis of the individual & combination of various markers have
revealed interesting findings of maternal outcome, some of them having statistically
significant.
Keywords:
    Nuchal Translucensy(NT) Pregnancy Associated Plasma Protein A(PAPPA) Ductus venosus flow(DVF)
  • PDF (216 K)
  • XML
(2022). Study on early detection of chromosomal anomalies, maternal outcome by performing biochemical and sonological tests between 11-14 wk of gestational age. European Journal of Molecular & Clinical Medicine, 9(3), 10308-10318.
Dr Sudha Bhimavarapu, Dr A Rohini, Dr. VBhanupriya. "Study on early detection of chromosomal anomalies, maternal outcome by performing biochemical and sonological tests between 11-14 wk of gestational age". European Journal of Molecular & Clinical Medicine, 9, 3, 2022, 10308-10318.
(2022). 'Study on early detection of chromosomal anomalies, maternal outcome by performing biochemical and sonological tests between 11-14 wk of gestational age', European Journal of Molecular & Clinical Medicine, 9(3), pp. 10308-10318.
Study on early detection of chromosomal anomalies, maternal outcome by performing biochemical and sonological tests between 11-14 wk of gestational age. European Journal of Molecular & Clinical Medicine, 2022; 9(3): 10308-10318.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 78
  • PDF Download: 101
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus